Biotech Co. Can't Defend Fundraising Claims, SEC Says
Federal securities regulators say a Colorado biotech company and its founders intended to dupe investors into giving more when they overstated their own fundraising and personal contributions to the venture by...To view the full article, register now.
Already a subscriber? Click here to view full article